Article
Endoglin-Aptamer-Functionalized Liposome-Equipped PD-1-Silenced T Cells Enhance…
International Journal of Nanomedicine · 2021 · Xie S, Hou X, Yang W, Shi W, Yang X, Duan S, Mo F, Liu A, Wang W, Lu X
Key facts
| Title | Endoglin-Aptamer-Functionalized Liposome-Equipped PD-1-Silenced T Cells Enhance Antitumoral Immunotherapeutic Effects |
|---|---|
| First author | Xie S, Hou X, Yang W, Shi W, Yang X, Duan S, Mo F, Liu A, Wang W, Lu X |
| Journal | International Journal of Nanomedicine |
| Published | Aug 31, 2021 |
| DOI | 10.2147/IJN.S317220 |
| Devices mentioned | BK110039, DEN000008, K022086, K071580, K103302 |
| Product codes mentioned | CIT, NDS, PCA, JCI, KIP, KIT, NJT, OOI |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1